These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11788047)

  • 1. Immunotherapeutic strategies for prevention and treatment of Alzheimer's disease.
    Solomon B
    DNA Cell Biol; 2001 Nov; 20(11):697-703. PubMed ID: 11788047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological approach for the treatment of Alzheimer's disease.
    Solomon B
    J Mol Neurosci; 2003; 20(3):283-6. PubMed ID: 14501009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease immunotherapy: from in vitro amyloid immunomodulation to in vivo vaccination.
    Solomon B
    J Alzheimers Dis; 2006; 9(3 Suppl):433-8. PubMed ID: 16914882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease and immunotherapy.
    Solomon B
    Curr Alzheimer Res; 2004 Aug; 1(3):149-63. PubMed ID: 15975063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological approaches as therapy for Alzheimer's disease.
    Solomon B
    Expert Opin Biol Ther; 2002 Dec; 2(8):907-17. PubMed ID: 12517269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripherally administered sera antibodies recognizing amyloid-β oligomers mitigate Alzheimer's disease-like pathology and cognitive decline in aged 3× Tg-AD mice.
    Wang HC; Yu YZ; Liu S; Zhao M; Xu Q
    Vaccine; 2016 Apr; 34(15):1758-66. PubMed ID: 26945100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards Alzheimer's beta-amyloid vaccination.
    Frenkel D; Solomon B
    Biologicals; 2001; 29(3-4):243-7. PubMed ID: 11851323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-amyloidbased immunotherapy as a treatment of Alzheimers disease.
    Solomon B
    Drugs Today (Barc); 2007 May; 43(5):333-42. PubMed ID: 17724499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunotherapy of Alzheimer's disease. Results of experimental investigations and treatment of perspectives].
    Karkos J
    Fortschr Neurol Psychiatr; 2004 Apr; 72(4):204-19. PubMed ID: 15095177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of anti-beta-amyloid antibodies via phage display technology towards Alzheimer's disease vaccination.
    Solomon B
    Vaccine; 2005 Mar; 23(17-18):2327-30. PubMed ID: 15755621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization against Alzheimer's beta -amyloid plaques via EFRH phage administration.
    Frenkel D; Katz O; Solomon B
    Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11455-9. PubMed ID: 11027345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Filamentous bacteriophage as a novel therapeutic tool for Alzheimer's disease treatment.
    Solomon B
    J Alzheimers Dis; 2008 Oct; 15(2):193-8. PubMed ID: 18953108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of auto-antibodies towards Alzheimer's disease vaccination.
    Frenkel D; Kariv N; Solomon B
    Vaccine; 2001 Mar; 19(17-19):2615-9. PubMed ID: 11257400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological approaches for amyloid-beta clearance toward treatment for Alzheimer's disease.
    Solomon B
    Rejuvenation Res; 2008 Apr; 11(2):349-57. PubMed ID: 18341423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of anti-beta-amyloid antibodies via phage display technology.
    Frenkel D; Dori M; Solomon B
    Vaccine; 2004 Jun; 22(19):2505-8. PubMed ID: 15193416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined treatment of amyloid-β₁₋₄₂-stimulated bone marrow-derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in APPswe/PSENldE9 mice.
    Wang F; Liu H; Shen X; Ao H; Moore N; Gao L; Chen L; Hu H; Ma H; Yang Z; Zhai C; Qin J; Zhou G; Peng Y; Feng X; Li R; Liang C
    Neurobiol Aging; 2015 Jan; 36(1):111-22. PubMed ID: 25085784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of beta-amyloid plaques in brain of transgenic mouse model of Alzheimer's disease by EFRH-phage immunization.
    Frenkel D; Dewachter I; Van Leuven F; Solomon B
    Vaccine; 2003 Mar; 21(11-12):1060-5. PubMed ID: 12559780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active immunization against Alzheimer's beta-amyloid peptide using phage display technology.
    Solomon B
    Vaccine; 2007 Apr; 25(16):3053-6. PubMed ID: 17287054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of endogenous neurogenesis by anti-EFRH immunization in a transgenic mouse model of Alzheimer's disease.
    Becker M; Lavie V; Solomon B
    Proc Natl Acad Sci U S A; 2007 Jan; 104(5):1691-6. PubMed ID: 17242369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.
    Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Logroscino G; Santamato A; Greco A; Seripa D; Pilotto A
    Immunotherapy; 2012 Feb; 4(2):213-38. PubMed ID: 22339463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.